Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Regenexx Cayman is a premier regenerative medicine center located in the Cayman Islands that specializes in advanced orthopedic stem cell treatments. As the international flagship of the Regenexx network, it offers the Regenexx-C procedure, which involves the laboratory culture-expansion of a patient's own mesenchymal stem cells to achieve therapeutic doses not possible in standard same-day procedures. The company focuses on treating chronic musculoskeletal conditions, including severe osteoarthritis and complex spine injuries, through non-surgical, image-guided injections. By maintaining a comprehensive patient outcomes database and adhering to rigorous laboratory protocols, Regenexx Cayman provides a data-driven alternative to invasive orthopedic surgeries. Their facility operates under local regulations that permit advanced cell processing techniques currently restricted in other jurisdictions like the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Regenexx Cayman.